Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

CEO David Joyner tells Yahoo Finance he's working to define the company. President Trump ... which suggests that Eli Lilly’s... GLP-1 drug prices are falling. That's good news for patients ...

Eli Lilly said ... oral cancer drug from Scorpion Therapeutics. Get top local San Diego stories delivered to you every morning with our News Headlines newsletter. The company maintained its ...

Eli Lilly on Thursday reported first-quarter revenue and earnings that topped estimates as demand for its weight loss and diabetes drugs soared, but lowered its full-year profit guidance due to ...

referring to those older drugs. He spoke after Eli Lilly reported first-quarter earnings and 2025 guidance, which did not include estimated effects of the potential pharmaceutical tariffs.

Thank you for joining us for Eli Lilly & Company's Q1 2025 earnings call ... And as you said, it's an event based study, so the timeline for the readout is driven by this. And although our ...

Eli Lilly on Thursday ... oral cancer drug from Scorpion Therapeutics. Get local news you need to know to start your day with NBC 6's News Headlines newsletter. The company maintained its fiscal ...

Eli Lilly said ... of a certain oral cancer drug from Scorpion Therapeutics. The company maintained its fiscal 2025 sales guidance of $58 billion to $61 billion. Eli Lilly said the guidance ...